Seed stage investing in pharma and biotech companies is a little different than seed stage investing in other sectors. When pharma and biotech companies approach crowdfunders, they’re usually pre-clinical — which means that human trials haven’t begun yet. And they’re raising amounts of money that can’t possibly sustain them long-term. So why do they want crowdfunders to invest? And what should investors look at as they evaluate these startups? Andy Gordon and Vin Narayanan answer these questions and more in this edition of Startup Insider.
Thanks for watching!